PPBT 241220 15.00P (PPBT241220P15000) Stock Options, News & Quotes

10.80
0.000.00%

15min DelayClose Dec 10 16:00 ET

0.00High0.00Low

SymbolStock Name

PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Jaguar8

Dec 5 06:13

NEWS

$Purple Biotech (PPBT.US)$
Purple Biotech Announces Closing of $2.8 Million Registered Direct Offering of American Depositary Shares
Thursday, 5th December at 7:13 am
REHOVOT, Israel, Dec. 05, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced the closing of its previously announced registered direct offering o...

Ken2win

Dec 3 07:51

$Purple Biotech (PPBT.US)$ all in today

PaulG

Dec 3 07:41

$Purple Biotech (PPBT.US)$ Lol..a previous press release said they had enough money until late 2025.. .then today...another offering at 6.00. Liars!

standalee31

Dec 3 07:25

Naughty, naughty

$Purple Biotech (PPBT.US)$

Jaguar8

Dec 3 07:23

NEWS

$Purple Biotech (PPBT.US)$
Purple Biotech Announces $2.8 Million Registered Direct Offering of American Depositary Shares
Tuesday, 3rd December at 8:23 am
REHOVOT, Israel, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. ("Purple Biotech" or the "Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today announced that it has entered into a definitive agreement for the purchase and sale of 472,...